Common Myths About TOT and Liver and Prostate Health
By Jay Campbell
January 10th, 2019
In recent years, there have been comments about the negative impact of TOT therapy. What many people fail to understand is that there are various side-effects to TOT treatment, but these are not life-threatening and in many cases are the result of either lousy diagnosis or misuse of therapy by either patients or their physicians. Two of the most common myths about TOT concern liver and prostate health. However, numerous studies on the subject have published, all of which are conclusive in their findings that TOT has no adverse side-effects in these matters. To better understand what causes liver and prostate failure, here is an insight into the effects of testosterone treatment on these two vital organs.
Many people believe that elevated testosterone levels may lead to liver toxicity. The assumption is patently false, and not based on any real-world data. There have been no documented cases of benign or malignant hepatic (liver) tumors with the use of injectable or transdermal TOT. After nearly 15 years of active physician-guided TOT, there were never elevated (i.e., out of range) liver panels. On the other hand, detrimental lifestyle habits such as over-consuming alcohol, eating diets high in saturated fats, and failing to exercise will stress your liver far more than TOT ever could. At the same time, those very same detrimental lifestyle habits dramatically increase the prevalence of Fatty Liver Disease, more specifically known as Non-Alcoholic Fatty Liver Disease (NAFLD).
You do NOT want to be diagnosed with NAFLD. You can avoid this by living an insulin-controlled lifestyle, minimizing alcohol consumption and focusing on your physical fitness. So whether you’re currently living a ‘clean’ lifestyle or not, you can see the importance of having your liver enzymes measured once a year. If you experience any elevation in your liver enzymes, supplementing with N-Acetyl-Cysteine (NAC) and Tauroursodeoxycholic acid (TUCA) is an optimal approach to lowering elevated panel readings.
PSA (Prostate-Specific Antigen) & Prostate Health
It’s also important to have a yearly PSA screening while on TOT. Even with all the sensationalist claims in the media about how testosterone causes prostate cancer and benign prostatic hyperplasia (BPH), there is no conclusive evidence that TOT increases the risk of either prostate cancer or BPH279. The most strong research data on TOT and prostate cancer destroys the long-held belief that greater total testosterone concentrations lead to cancer growth.
The recent findings disprove the theory entirely. The most plausible explanation is that low testosterone levels are supposedly the cause of prostate cancer. It is supported by the recently re-evaluated saturation model which states that secondary to limited androgen receptor binding sites. Prostate cancer growth is sensitive to variations in total testosterone levels that are only below castrated range (supremely low levels.)
In other words, optimized levels of testosterone are NOT the culprit – low testosterone levels are. High blood levels of testosterone do not increase the risk of prostate cancer. Treatment with testosterone does not increase the risk of prostate cancer, even among men who are already at high risk for it. As a man, it’s essential to monitor the health of your liver and prostate. Take the time to speak to your doctor about the positive aspects of TOT therapy, and how increased testosterone can improve your health. Get the TOT Bible today to find out more about the treatment.